SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients

BACKGROUND: Although SARS-CoV-2 vaccines have proven effective in eliciting a protective immune response in healthy individuals, their ability to induce a durable immune response in immunocompromised individuals remains poorly understood. Primary antibody deficiency (PAD) syndromes are among the mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Frank J., Doss, Alexa Michelle Altman, Davis-Adams, Hannah G., Adams, Lucas J., Hanson, Christopher H., VanBlargan, Laura A., Liang, Chieh-Yu, Chen, Rita E., Monroy, Jennifer Marie, Wedner, H. James, Kulczycki, Anthony, Mantia, Tarisa L., O’Shaughnessy, Caitlin C., Raju, Saravanan, Zhao, Fang R., Rizzi, Elise, Rigell, Christopher J., Dy, Tiffany Biason, Kau, Andrew L., Ren, Zhen, Turner, Jackson S., O’Halloran, Jane A., Presti, Rachel M., Fremont, Daved H., Kendall, Peggy L., Ellebedy, Ali H., Mudd, Philip A., Diamond, Michael S., Zimmerman, Ofer, Laidlaw, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817149/
https://www.ncbi.nlm.nih.gov/pubmed/36618402
http://dx.doi.org/10.3389/fimmu.2022.1033770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817149/
https://www.ncbi.nlm.nih.gov/pubmed/36618402
http://dx.doi.org/10.3389/fimmu.2022.1033770

Ejemplares similares